ACADIA Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACAD and other ETFs, options, and stocks.About ACAD
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis.
ACAD Key Statistics
Stock Snapshot
With a market cap of 4.5B, ACADIA Pharmaceuticals(ACAD) trades at $26.60. The stock has a price-to-earnings ratio of 16.36.
On 2025-12-04, ACADIA Pharmaceuticals(ACAD) stock moved within a range of $25.40 to $26.61. With shares now at $26.60, the stock is trading +4.7% above its intraday low and -0.0% below the session's peak.
Trading activity shows a volume of 1.12M, compared to an average daily volume of 1.36M.
Over the past 52 weeks, ACADIA Pharmaceuticals(ACAD) stock has traded between a high of $26.65 and a low of $13.40.
Over the past 52 weeks, ACADIA Pharmaceuticals(ACAD) stock has traded between a high of $26.65 and a low of $13.40.
ACAD News
ACADIA Pharmaceuticals recently presented at Citi’s Annual Global Healthcare Conference 2025 in Miami, highlighting its progress in central nervous system and r...
